Page 15 - Read Online
P. 15

Page 8 of 9                                        Cosgun et al. Mini-invasive Surg 2019;3:32  I  http://dx.doi.org/10.20517/2574-1225.2019.024

               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2019.



               REFERENCES
               1.   Yu X, Li Y, Shi C, Han B. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A
                   monocentric population-based analysis. Thorac Cancer 2018;9:3-9.
               2.   Takizawa H, Kondo K, Matsuoka H, Uyama K, Toba H, et al. Effect of mediastinal lymph nodes sampling in patients with clinical
                   stage I non-small cell lung cancer. J Med Invest 2008;55:37-43.
               3.   Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, et al. Early and locally advanced non-small-cell lung cancer (NSCLC):
                   ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:89-98.
               4.   Moon Y, Kim KS, Lee KY, Sung SW, Kim YK, et al. Clinicopathologic factors associated with occult lymph node metastasis in
                   patients with clinically diagnosed N0 lung adenocarcinoma. Ann Thorac Surg 2016;101:1928-35.
               5.   Ettinger DS, Akerley W, Borghaei H, Akerley W, Bauman J, et al. Non-small cell lung cancer. J Natl Compr Canc Netw 2012;10:1236-71.
               6.   Gulack BC, Yang CF, Speicher PJ, Meza JM, Gu L, et al. The impact of tumor size on the association of the extent of lymph node
                   resection and survival in clinical stage I non-small cell lung cancer. Lung Cancer 2015;90:554-60.
               7.   Watanabe S, Oda M, Go T, Ohta Y, Watanabe Y, et al. Should mediastinal nodal dissection be routinely undertaken in patients with
                   peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg 2001;20:1007-11.
               8.   Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, et al. International association for the study of lung cancer/
                   American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J
                   Thorac Oncol 2011;6:244-85.
               9.   Toker A, Kaba E, Ayalp K, Ozyurtkan MO. Robotic lung resections: video-assisted thoracic surgery based approach. J Vis Surg
                   2017;3:15.
               10.   Toker A, Ozyurtkan MO, Demirhan O, Ayalp K, Kaba E, et al. Lymph node dissection in surgery for lung cancer: Comparison of open
                   vs. video-assisted vs. robotic-assisted approaches. Ann Thorac Cardiovasc Surg 2016;22:284-90.
               11.   Zang RC, Qiu B, Gao SG, He J. A model predicting lymph node status for patients with clinical stage T1aN0-2M0 nonsmall cell lung
                   cancer. Chin Med J (Engl) 2017;130:398-403.
               12.   Gard G, Voskoboynik M. Delay to Surgery May Upstage Patients With Non-Small Cell Lung Cancer.  Chest 2019;156:633-4. doi:
                   10.1016/j.chest.2019.04.113.
               13.   Stiles BM, Mao J, Harrison S, Lee B, Port JL et al. Extent of lymphadenectomy is associated with oncological efficacy of sublobar
                   resection for lung cancer ≤ 2 cm. J Thorac Cardiovasc Surg 2019;157:2454-65.
               14.   Bao F, Yuan P, Yuan X, Lv X, Wang Z, et al. Predictive risk factors for lymph node metastasis in patients with small size non-small
                   cell lung cancer. J Thorac Dis 2014;6:1697-703.
               15.   Pan T, Zheng Z, Li J, Tang Y, Pan Y, et al. Relationship between tumor size and lymph node metastasis in squamous cell carcinoma
                   and adenocarcinoma of the lung. Zhongguo Fei Ai Za Zhi 2006;9:267-9.
               16.   Seok Y, Yang HC, Kim TJ, Lee KW, Kim K, et al. Frequency of lymph node metastasis according to the size of tumors in resected
                   pulmonary adenocarcinoma with a size of 30 mm or smaller. J Thorac Oncol 2014;9:818-24.
               17.   Jin C, Cao J, Cai Y, Wang L, Liu K, et al. A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with
                   solitary peripheral subsolid nodules. J Thorac Cardiovasc Surg 2017;153:462-9.
               18.   Wang L, Shen W, Xi Y, Liu S, Zheng D, et al. Nomogram for predicting the risk of invasive pulmonary adenocarcinoma for pure
                   ground-glass nodules. Ann Thorac Surg 2018;105:1058-64.
               19.   Moon Y, Sung SW, Namkoong M, Park JK. The effectiveness of mediastinal lymph node evaluation in a patient with ground glass
                   opacity tumor. J Thorac Dis 2016;8:2617-25.
               20.   Yu Y, Jian H, Shen L, Zhu L, Lu S. Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤ 3 cm
                   disease: A study of 2268 cases. Eur J Surg Oncol 2016;42:1714-9.
   10   11   12   13   14   15   16   17   18   19   20